Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Withdraw the needle at the same angle you inserted it
TransCon PTH Hypoparathyroidism (adolescents) Phase 3 Multinational TransCon CNP Achondroplasia (infants) Pivotal Phase 2 Multinational TransCon CNP Achondroplasia (adolescents) Pivotal Phase 2b Multinational TransCon CNP Hypochondroplasia (children aged 2-18) Phase 3 Multinational TransCon CNP + TransCon hGH Achondroplasia (children aged 2-11) Phase 2 Multinational TransCon CNP + TransCon hGH Achondroplasia (children aged 2-18) Phase 3 Multinational TransCon CNP + TransCon hGH Hypochondroplasia (children aged 2-18) Phase 3 Multinational Partner Programs TransCon hGH Pediatric GHD BLA submitted China TransCon hGH Pediatric GHD Phase 3 Japan TransCon PTH Hypoparathyroidism (adults) Completed Phase 3 China TransCon CNP Achondroplasia Completed Phase 2 China TransCon CNP Achondroplasia Phase 3 Japan Oncology Indication Status Region Lead Indication TransCon IL-2 / Various tumor types Phase 2 Multinational Note: The above chart lists our current clinical interventional trials related to the disclosed indications
Weight loss varies, but many patients experience gradual, sustained reduction when combined with lifestyle changes and medical supervision
MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity
Huang, H.-C., Nguyen, T
By late 2021, cracks appeared
